A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease
Status:
SUSPENDED
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to compare the efficacy and safety of tanfanercept ophthalmic solution 0.25% and 1.0% to vehicle for the treatment of DED.